ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Overall Toxicities With Immunotherapy in Melanoma – OncLive

OncLiveOverall Toxicities With Immunotherapy in MelanomaOncLiveInsights From: Michael A. Postow, MD, Memorial Sloan Kettering Cancer Center; Claire Crowley, RN, Memorial Sloan Kettering Cancer Center; Michael B. Atkins, MD, Georgetown Lombardi Comprehe… Continue reading

2017-03-06 Michael Zand NEWS

Expert Discusses JCAR017 CAR T-Cell Therapy in Non-Hodgkin Lymphoma – OncLive

Continue reading

2017-03-06 Michael Zand NEWS

Could you save his life? Edmonton boy needs to find stem cell match – Globalnews.ca


OncLive

Expert Discusses JCAR017 CAR T-Cell Therapy in Non-Hodgkin Lymphoma
OncLive
“This is an important, exciting, and possibly new paradigm for treating lymphoma but the data are still early,” explained Leo I. Gordon MD, director of the Lymphoma Program in the Division of Hematology/Oncology at the Northwestern University Feinberg …
‘Extraordinary’ new cancer drug appears to cure a third of terminal …The Independent
BioNews – Remission in one-third of terminal lymphoma patients …BioNews
Cancer Cure News 2017: New Gene Therapy Treatment May …Christian Post
Seeking Alpha
all 4 news articles »
Continue reading

2017-03-06 Michael Zand NEWS

New CRISPR-Cas, Gene Editing Systems, Discovered in Vast DNA … – Newswise (press release)

New CRISPR-Cas, Gene Editing Systems, Discovered in Vast DNA …Newswise (press release)Researchers discover the first CRISPR-Cas9 system in archaea, which may enable new technologies for biological research.and more &raquo… Continue reading

2017-03-06 Michael Zand NEWS

Remuneration for Gene Therapy Treatments: ICER Provides Early Recommendations – AJMC.com Managed Markets Network

Remuneration for Gene Therapy Treatments: ICER Provides Early RecommendationsAJMC.com Managed Markets NetworkIn its latest white paper, the Institute for Clinical and Economic Review (ICER) provides a summary of a 2016 policy summit on gene therapy, di… Continue reading

2017-03-06 Michael Zand NEWS

Induced Pluripotent Stem Cells May Hold Key To Reversing Aging – Wall Street Pit


Globalnews.ca

Could you save his life? Edmonton boy needs to find stem cell match
Globalnews.ca
Another stem cell swab event is taking place on Thursday with the hopes of finding a match for an eight-year-old Edmonton boy with leukemia. In November, Brady Mishio’s dad took him to the hospital because he thought he had the flu. “Quickly they did …

Continue reading

2017-03-06 Michael Zand NEWS

Gene therapy lets a French teen dodge sickle cell disease – CBS News


Wall Street Pit

Induced Pluripotent Stem Cells May Hold Key To Reversing Aging
Wall Street Pit
Knowing how blood cells became less functional with age, what they did was provide the mice with induced pluripotent stem (iPS) cells — stem cells that can produce any kind of cell not just blood cells — and the result was nothing short of amazing …

Continue reading

2017-03-06 Michael Zand NEWS

Remission in one-third of terminal lymphoma patients after gene therapy – BioNews


CBS News

Gene therapy lets a French teen dodge sickle cell disease
CBS News
A French teen who was given gene therapy for sickle cell disease more than two years ago now has enough properly working red blood cells to dodge the effects of the disorder, researchers report. The first-in-the-world case is detailed in Thursday’s New …
Sickle cell anemia patient ‘cured’ by gene therapy, doctors sayFOX 61
In a first, gene therapy cures teen with sickle cell diseaseEconomic Times
Case Report: Sickle Cell Disease Gene TherapyRare Disease Report
BioNews –BBC News –New England Journal of Medicine
all 78 news articles »
Continue reading

2017-03-06 Michael Zand NEWS
  • 1
  • …
  • 2,013
  • 2,014
  • 2,015
  • 2,016
  • 2,017
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Remission in one-third of terminal lymphoma patients after gene therapy
BioNews
The trial used genetically modified cells taken from the patient’s own immune system, known as CAR-T therapy. After six months, cancer had shrunk by at least half in 82 percent of patients with non-Hodgkin lymphoma. ‘The numbers are fantastic,’ said Dr …

and more »